Evidence map›Paper›PMID 12532431›Full record

ReviewWorld journal of gastroenterology2003

Hepatic stem cells: existence and origin.

Ying Zhang, Xue-Fan Bai, Chang-Xing Huang

Abstract readReview
In one paragraph

Review in World journal of gastroenterology, 2003. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 19 papers.

0numbers the graph read from it
0cells of the map it votes in
19citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

19 citing papers in PubMed.

  1. Review
  2. Review
  3. Article
  4. Mechanisms of hepatocellular carcinoma progression.World journal of gastroenterology · 2019
    Review
  5. Article
  6. Review
  7. Article
  8. Article
  9. Review
  10. Article
  11. Engineering complex tissues.Tissue engineering · 2006
    Review
  12. Article
  13. An in vitro study of hematopoietic progenitor cells from peripheral blood of rabbits.Canadian journal of veterinary research = Revue canadienne de recherche veterinaire · 2005
    Article
  14. Adult stem cells and cancer stem cells: tie in or tear apart?Journal of cancer research and clinical oncology · 2005
    Review
  15. Article
  16. Article
  17. Possible stem cell origin of human cholangiocarcinoma.World journal of gastroenterology · 2004
    Article
  18. Article
  19. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

3 authors.

Ying ZhangThe center of diagnosis and treatment for infectious diseases of PLA, Tang Du Hospital, Fourth Military Medical University, Xi'an 710038, Shaanxi Province, China.
Xue-Fan Bai
Chang-Xing Huang

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Stem cells are not only units of biological organization, responsible for the development and the regeneration of tissue and organ systems, but also are units in evolution by natural selection. It is accepted that there is stem cell potential in the liver. Like most organs in a healthy adult, the liver maintains a perfect balance between cell gain and loss. It has three levels of cells that can respond to loss of hepatocytes: (1) Mature hepatocytes, which proliferate after normal liver tissue renewal, less severe liver damage, etc; they are numerous, unipotent, "committed" and respond rapidly to liver injury. (2) Oval cells, which are activated to proliferate when the liver damage is extensive and chronic, or if proliferation of hepatocytes is inhibited; they lie within or immediately adjacent to the canal of Hering (CoH); they are less numerous, bipotent and respond by longer, but still limited proliferation. (3) Exogenous liver stem cells, which may derive from circulating hematopoietic stem cells (HSCs) or bone marrow stem cells; they respond to allyl alcohol injury or hepatocarcinogenesis; they are multipotent, rare, but have a very long proliferation potential. They make a more significant contribution to regeneration, and even completely restore normal function in a murine model of hereditary tyrosinaemia. How these three stem cell populations integrate to achieve a homeostatic balance remains enigmatic. This review focuses on the location, activation, markers of the three candidates of liver stem cell, and the most importantly, therapeutic potential of hepatic stem cells.

Indexed as

AnimalsBone Marrow CellsCell DivisionCell LineHepatocytesHumansLiverStem Cells

Identifiers

PMID12532431
PMCPMC4611311

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.